No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 63-66

  Valdés, Patricio ^a   Cerda, Alvaro ^a   Barrenechea, Cristobal ^a   Kehr, Marlene ^a   Soto, Carolina ^a   Salazar, Luis A ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

G972R; Insulin receptor substrate 1; Polycystic ovary syndrome; Single nucleotide polymorphisms

Indexed keywords

ARGININE; CHOLESTEROL; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CHILE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; IRS-1 GENE; LIPID BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ARGININE; CASE-CONTROL STUDIES; CHILE; FEMALE; GENE FREQUENCY; GENOTYPE; GLYCINE; HUMANS; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME;

EID: 39849093269     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.018     Document Type: Article

References (35)

1. Dunaif A., and Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 52 (2001) 401-419
2. Norman R.J., Dewailly D., Legro R.S., and Hickey T.E. Polycystic ovary syndrome. Lancet 370 (2007) 685-697
3. Cussons A.J., Stuckey B.G., and Watts G.F. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 185 (2006) 227-239
4. Cussons A.J., Stuckey B.G., and Watts G.F. Metabolic syndrome and cardiometabolic risk in PCOS. Curr Diabetes Rep 7 (2007) 66-73
5. Diamanti-Kandarakis E., and Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 11 (2005) 631-643
6. Luque-Ramírez M., San Millán J.L., and Escobar-Morreale H.F. Genomic variants in polycystic ovary syndrome. Clin Chim Acta 366 (2006) 14-26
7. Haap M., Machicao F., Stefan N., et al. Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 113 (2005) 275-281
8. Sesti G., Federici M., Hribal M., Lauro D., Sbraccia P., and Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15 (2001) 2099-2111
9. Ogihara T., Isobe T., Ichimura T., et al. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J Biol Chem 272 (1997) 25267-25274
10. Garcia P., Shoelson S.E., George S.T., Hinds D.A., Goldberg A.R., and Miller W.T. Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro. J Biol Chem 268 (1993) 25146-25151
11. McGettrick A.J., Feener E.P., and Kahn C.R. Human insulin receptor substrate-1 (IRS-1) polymorphism G972R causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation. J Biol Chem 280 (2005) 6441-6446
12. Morrison V.A., Onengut-Gumuscu S., and Concannon P. A functional variant of IRS1 is associated with type 1 diabetes in families from the US and UK. Mol Genet Metab 81 (2004) 291-294
13. Tok E.C., Ertunc D., Bilgin O., Erdal E.M., Kaplanoglu M., and Dilek S. Association of insulin receptor substrate-1 G972R variant with baseline characteristics of the patients with gestational diabetes mellitus. Am J Obstet Gynecol 194 (2006) 868-872
14. Dilek S., Ertunc D., Tok E.C., Erdal E.M., and Aktas A. Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome. Fertil Steril 84 (2005) 407-412
15. Sir-Petermann T., Perez Bravo F., Angel B., Maliqueo M., Calvillan M., and Palomino A. G972R polymorphism of IRS-1 in women with polycystic ovary syndrome. Diabetologia 44 (2001) 1200-1201
16. Kauffman R.P., Baker V.M., Dimarino P., Gimpel T., and Castracane V.D. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 187 (2002) 1362-1369
17. Wijeyaratne C.N., Balen A.H., Barth J.H., and Belchetz P.E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf) 57 (2002) 343-350
18. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Cambridge, United Kingdom 377-384
19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
20. Salazar L.A., Hirata M., Cavalli S., et al. Optimized procedure DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 44 (1998) 1748-1750
21. Almind K., Bjorbaek C., Vestergaard H., Hansen T., Echwald S., and Pedersen O. Amino acid polymorphism of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342 (1993) 828-832
22. San Millán J., Corton M., Villuendas G., et al. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 89 (2002) 2640-2646
23. González A., Abril E., Roca A., et al. CAPN 10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 3971-3976
24. Orio F., Matarese G., Biase S., et al. Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphism in polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 5887-5893
25. Dabadghao P., Roberts B.J., Wang J., Davies M.J., and Norman R.J. Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust 187 (2007) 328-331
26. Shroff R., Kerschner A., Maifeld M., Van Beek E.J., Jagasia D., and Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab 96 (2007) 4609-4614 (Electronic publication 2007 Sep 11)
27. Rocco P., Morales C., Moraga M., et al. Genetic composition of the Chilean population. Analysis of mitochondrial DNA polymorphism. Rev Med Chil 130 2 (2002) 125-131
28. Ehrmann D.A., Tang X., Yoshiuchi I., Cox N.J., and Bell G.I. Relationship of Insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 4297-4300
29. Villuendas G., Botella-Carretero J.I., Roldan B., Sancho J., Escobar-Morreale H.F., and San Millán J.L. Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Hum Reprod 20 (2005) 3184-3191
30. El Mkaden S.A., Lautier C., Macari F., et al. Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50 (2001) 2164-2168
31. Baba T., Endo T., Sata F., et al. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population. Life Sci 81 (2007) 850-854
32. Lin T.C., Yen J.M., Gong K.B., et al. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population-not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism. BMC Med Genet 7 (2006) 36
33. Ertunc D., Tok E.C., Aktas A., Erdal E.M., and Dilek S. The importante of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome. Hum Reprod 20 (2005) 1207-1212
34. Sir-Petermann T., Angel B., Maliqueo M., et al. Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load. Nutr 20 (2004) 905-910
35. Colhoun H.M., McKeigue P.M., and Davey-Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 (2003) 865-872